RecruitingPhase 3NCT07545395

Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

Studying Hemophilia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Suzhou Alphamab Co., Ltd.
Principal Investigator
Renchi Yang, Doctor
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Intervention
KN057(drug)
Enrollment
70 enrolled
Eligibility
12-65 years · MALE
Timeline
20262028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07545395 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia

← Back to all trials